- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Cabozantinib is a multi-target tyrosine kinase inhibitor that is suitable for the treatment of various cancers. The dosage should be adjusted a...
When taking cabozantinib, attention should be paid to fasting or with meals, and the principles of missed doses and discontinuation of medicati...
Cabozantinib is contraindicated for patients with severe liver injury and active bleeding, as its use may pose a fatal risk. The following item...
During the use of cabozantinib, special attention should be paid to monitoring and managing hypertension, diarrhea, and hand foot syndrome. H...
The contraindications for Lumakras/AMG510 mainly include patients with severe liver injury and pregnant women, and strict adherence to medicati...
As a targeted drug, the monitoring and management of adverse reactions such as liver toxicity, interstitial lung disease, and diarrhea should b...
Sutoraxib (trade name Lumakras/AMG510) is a targeted drug used for specific cancers, with a standard dose of 960mg orally per day. Attention sh...
Sotorasib is the first approved KRASG12C targeted inhibitor for the treatment of non-small cell lung cancer (NSCLC) carrying this mutation. The...
The contraindications for Fasturtec include patients with G6PD deficiency and previous allergies, and strict screening is necessary to avoid se...
The possible side effects such as fever, vomiting, and rash during treatment with Fasturtec require targeted management. The following systemat...
